Gynecology & Obstetrics
Open Access
ISSN: 2161-0932
ISSN: 2161-0932
Cheng-Tao Lin
People's Republic of China
Case Report
Immunotherapy with Immunomodulatory Agents Prolong Survival of Advanced Ovarian Cancer with Brain Metastatis
Author(s): Hsiu-Huei Peng, Kun-Ju Lin and Cheng-Tao Lin
Hsiu-Huei Peng, Kun-Ju Lin and Cheng-Tao Lin
The prognosis of patients with metastatic ovariancancer is poor. Treatment with surgery and chemotherapeutic drugs alone is rarely curative. In the past few years, the development of immunotherapy, targeted therapy, angiogenesis inhibitors, and tyrosine kinase inhibitors has provided better treatment choices for patients with metastatic ovarian cancer.
A 62-year-old woman was diagnosed on October 2008, with advanced ovarian cancer, stage IIIc. She underwent maximal debulking surgery (including abdominal total hysterectomy, bilateral salpingo-oophorectomy, total omentectomy, excision of multiple peritoneal carcinomatosis, bilateral pelvic lymph node dissection, and end-to-end enteroanastomosis) with concurrent intraperitoneal treatment by hyperthermia lavage (5000 ml, 43 cesium degree) with immunomodulatory agent celecoxib (cyclooxygenase-2 inhibitor) to create host immunosur.. View More»
DOI:
10.4172/2161-0932.1000411